Company intelligence / Profile preview

Nanosonics

Sydney, New South Wales, Australiananosonics.us ↗

Ownership: Private
Employees: ~300
Development stage: Commercial

Overview

Nanosonics has commercialized the trophon family of automated high-level disinfection devices for ultrasound probes. The technology has been adopted globally and used in over 100 million procedures, with demonstrated effectiveness against bacteria, fungi, mycobacteria, and viruses. The company continues to innovate in infection prevention workflows.

Therapeutic areas: Infectious Diseases
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

GE Ventures (investor)

Beyond the preview

Go deeper on Nanosonics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanosonics.

Explore the full profile